GlaxoSmithKline Pharmaceuticals Limited — Dividend/Bonus, 29-10-2024: Dividend

GlaxoSmithKline Pharmaceuticals Limited reported its financial results for the second quarter and half-year ending September 30, 2024, showing a revenue of ₹100,005 lakhs and a profit of ₹24,869 lakhs. The Board has declared a special interim dividend of ₹12 per equity share. Total assets increased to ₹373,009 lakhs from ₹354,780 lakhs, while cash and cash equivalents decreased to ₹3,849 lakhs. Overall, the company continues to exhibit stable financial performance.